Your Complete Guide to Global Clinical Research and GCP Compliance
Templates, Checklists and Governance Models for Robust Monitoring Plan & Risk Management Plan Templates, Checklists and Governance Models for Robust Monitoring Plan & Risk Management Plan In the landscape of clinical trials, particularly crohn’s disease clinical trials, establishing a robust Monitoring Plan (MP) and Risk Management Plan (RMP) is pivotal. This article aims to provide…
Digital Tools and Analytics for Near Real-Time Deviation Trending Digital Tools and Analytics for Near Real-Time Deviation Trending In the ever-evolving landscape of clinical trials, particularly in sensitive domains like ovarian cancer clinical trials, the need for robust monitoring and analytics is more pronounced than ever. The increase in trial complexity necessitates sophisticated tools for…
Read More “Digital Tools and Analytics for Near Real-Time Deviation Trending” »
Communicating Deviation Trends and CAPA Linkage to Sites and Vendors Communicating Deviation Trends and CAPA Linkage to Sites and Vendors In the realm of clinical trials, particularly under the purview of eisf clinical trials, effective communication regarding deviation trends and Corrective and Preventive Action (CAPA) linkage represents a vital component of compliance and operational excellence….
Read More “Communicating Deviation Trends and CAPA Linkage to Sites and Vendors” »
Integrating Patient Access to Results & Return of Data With Data Privacy, GDPR and HIPAA Requirements In the realm of clinical trials, the provision of patient access to results and the return of data is increasingly recognized as an essential aspect of ethical research and patient-centric care. However, navigating the complexities of data privacy regulations…
Vendor and Partner Oversight Considerations for Patient Access to Results & Return of Data In the realm of clinical research, ensuring patient access to results and the return of data are critical elements of operational integrity and regulatory compliance. This article provides a comprehensive step-by-step guide on vendor and partner oversight considerations, emphasizing the importance…
Digital-First Monitoring Plan & Risk Management Plan Strategies for Complex and Decentralized Trials Digital-First Monitoring Plan & Risk Management Plan Strategies for Complex and Decentralized Trials In the rapidly evolving landscape of clinical research, the necessity for agile methodologies such as digital-first monitoring and effective risk management plans (RMPs) cannot be overstated. Particularly for ulcerative…
Global Trending of Deviations Across US, EU and UK Programs Global Trending of Deviations Across US, EU and UK Programs In the landscape of clinical research, particularly in the context of good lab clinical trials, understanding the patterns of deviations can significantly affect compliance and study outcomes. Protocol deviations can lead to violations that impact…
Read More “Global Trending of Deviations Across US, EU and UK Programs” »
Metrics to Track CAPA Effectiveness on Deviation Reduction Metrics to Track CAPA Effectiveness on Deviation Reduction This article provides a comprehensive step-by-step tutorial focused on the metrics necessary to effectively track the impact of Corrective and Preventive Actions (CAPA) on the reduction of protocol deviations in clinical trials. The target audience includes professionals engaged in…
Read More “Metrics to Track CAPA Effectiveness on Deviation Reduction” »
KRIs, KPIs and Dashboards to Monitor Patient Access to Results & Return of Data Across Portfolios KRIs, KPIs and Dashboards to Monitor Patient Access to Results & Return of Data Across Portfolios In the modern landscape of clinical trials, monitoring patient access to results and ensuring a return of data is of paramount importance. This…
Case Studies: Patient Access to Results & Return of Data That Strengthened Public and Regulator Trust Case Studies: Patient Access to Results & Return of Data That Strengthened Public and Regulator Trust In the evolving landscape of clinical research, the emphasis on transparency and the return of clinical trial results to patients has become paramount….
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.